Ryne Sandberg

Ryne Sandberg opines on baseball’s steroid era


Phillies third base coach Ryne Sandberg is expected to be the next Phillies manager if and when the Charlie Manuel era ends. Sandberg started his playing career with the Phillies but went to the Cubs in the infamous Ivan de Jesus trade in 1982, arguably one of the worst trades in baseball history. With the Cubs, Sandberg would become one of the best second basemen ever to play the game. In recent years, he has worked his way up through the Minor Leagues as a coach.

MLB.com’s Barry M. Bloom peppered Sandberg with questions about his past when he managed in the Minor Leagues, what he expects in the future, and got Sandberg to opine on how the Hall of Fame should handle players from the steroid era.

Sandberg: I’m not a sportswriter. I don’t get to vote. I don’t get the ballot in the mail, so it’s out of my hands either way. I can say that in the history of the Hall of Fame, there are no suspicions about guys who are in the Hall of Fame. It’s an elite group. And once you’re in the Hall, you’re in the Hall. Up until now, I think the voting system has handled things very well. And like I said before, there are no suspicions in the Hall of Fame.

MLB.com: But in your speech, you did say that Andre Dawson should be in. You said, “He did it the right way, the natural way.” So you have voiced your opinion, even though you don’t have a vote.

Sandberg: But that wasn’t about drugs. That was about a player whose numbers, I thought, were being dwarfed by those put up in that era. I played with the guy and against him for most of my career. I saw most of his career. For a number of years, he was overshadowed by the guys who hit 60 or 70 home runs. Those numbers were astronomical and were numbers I could not relate to. I thought he was a Hall of Famer and had had a Hall of Fame career. That’s why I voiced my opinion on that, and I was very happy to see him go in.

Sandberg isn’t 100% right about there being “no suspicions in the Hall of Fame”. The Hall is rife with bat-corkers, ball-scuffers, spitballers, players who have taken amphetamines (e.g. Willie Mays, Hank Aaron, Mike Schmidt), and so forth. Not to mention the otherwise unsavory characters like Ty Cobb.

Older eras of baseball were just as impure as the steroid era has been purported to be. You see this a lot when older people talk about the younger generations. Take TIME Magazine’s latest cover, for instance, titled “The ME ME ME Generation”. Or their 1990 cover titled “twentysomething”, asking if the generation is “laid back, late blooming, or just lost?” People tend to romanticize the generation in which they were brought up and demonize ensuing generations. It seems like that’s what Sandberg is doing here, willfully glossing over his own generation’s seedy history to complain about those damn kids with their loud music and their steroids.

Zack Greinke deal “could come soon,” Dodgers and Giants lead the bidding

Zack Greinke
AP Photo/Mark J. Terrill

Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Monday for seven years, $217 million.

Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …

FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.

ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.

Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.

The Red Sox get their ace! Boston signs David Price to a 7-year, $217 million deal


Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.

This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.

Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.

The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.

Major League Baseball’s annual drug testing report has been released

Leave a comment

MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.

The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:

  • Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
  • 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
  • The previous year there were 7,929 total tests with 12 which resulted in discipline;
  • There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.

A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.

As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.

Twins sign Korean slugger Byung-ho Park to four-year contract

Byung-ho Park
Leave a comment

With a week remaining in their exclusive negotiating window to sign Byung-ho Park the Twins have agreed to a deal with the Korean slugger. Ken Rosenthal of FOXSports.com reports that it’s a four-year, $12 million contract, on top of which the Twins will pay Park’s old team a $12.85 million posting fee for those negotiating rights.

Four years and a total commitment of $24.85 million is certainly a sizable investment, but it’s significantly less than most projections had the Twins spending to get Park under contract.

Last offseason the Pirates bid $5 million to negotiate with Korean shortstop Jung Ho Kang and then signed him to a four-year, $11 million deal. His success in MLB raised the level of interest in Park, who posted similarly spectacular numbers in Korean, but in the end the price tag wasn’t significantly higher. Based on reports from Korea, it sounds like the Twins low-balled him in negotiations and Park basically just accepted it because he wants to play in MLB.

Three weeks ago I wrote a lengthy breakdown of how Park could fit into the Twins’ plans when they secured the high bid, but the short version is that he’ll slot into the lineup as the starting designated hitter and look to prove that his exceptional production in Korean can carry over to MLB. Park hit .343 with 53 homers, 146 RBIs, and a 1.150 OPS in 140 games for Nexen this past season and has topped a 1.000 OPS in each of the past three years.